Why the study?
Does percutaneous coronary intervention provide comparable outcomes to coronary artery bypass surgery in patients with unprotected left main coronary artery disease?
Does percutaneous coronary intervention provide comparable outcomes to coronary artery bypass surgery in patients with unprotected left main coronary artery disease?
Answers are grounded in this paper and cite their sources.
PCI is a safe and effective alternative to CABG for unprotected left main coronary artery disease in appropriately selected patients, though it is associated with higher rates of repeat revascularization.
Unprotected left main coronary artery (ULMCA) disease constitutes 5 to 7% of the patients undergoing coronary angiography.[1] It is associated with a high mortality as it supplies a large area of the myocardium—approximately 84% of the left ventricle in right dominant system and 100% in a left dominant system.[2] In CASS (Coronary Artery Surgery Study) registry, mortality in medically treated patients is as high as 63% at 5 years.[3]
No takes yet. Share an insight, caveat, or question.
Sujatha Vipperla (2018) conducted a review in Unprotected left main coronary artery (ULMCA) disease. Percutaneous coronary intervention (PCI) vs. Coronary artery bypass surgery (CABG) was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: